# Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

> **NCT02925247** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 150 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **BEHAVIORAL:** Adherence to oral anticoagulant treatment

## Key facts

- **NCT ID:** NCT02925247
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-27
- **Primary completion:** 2018-11-19
- **Final completion:** 2022-11-18
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02925247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02925247, "Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02925247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*